NicOx Announces Favorable Blood Pressure Data For Naproxcinod In A Large ABPM Study NicOx S.A. (Euronext Paris: COX) announced positive top-line results from a 118 patient Ambulatory Blood Pressure Monitoring (ABPM) trial (the 111 study), which compared the 24-hour blood pressure profile of escalating doses of naproxcinod and naproxen in osteoarthritis (OA) patients with controlled hypertension.
Source: www.medicalnewstoday.comNew Drug Stopped Mice Putting On Weight A European and American study on a new synthetic drug found that it protected laboratory mice from diet-induced obesity and its potential consequences like glucose intolerance and insensitivity to insulin by activating an enzyme that promoted fat consumption and exercise endurance, leading to suggestions that it could be an important new weapon in the fight against obesity and diabetes.
Source: www.medicalnewstoday.comGenzyme And Osiris Partner To Develop And Commercialize First-In-Class Adult Stem Cell Products Genzyme Corp. (Nasdaq: GENZ) and Osiris Therapeutics (Nasdaq: OSIR) announced today that they have entered a strategic alliance for the development and commercialization of Prochymal and Chondrogen, two novel, late-stage adult stem cell treatments that hold significant potential to treat a wide range of diseases. These stem-cell products are designed to provide therapeutic benefit by controlling inflammation, promoting tissue regeneration, and preventing scar formation.
Source: www.medicalnewstoday.comWomen's Hands Home To More Bacteria Human being have far more different kinds of bacteria on the palms of their hands than previously thought and women's hands are home to a more diverse range than men's, said US researchers this week.
Source: www.medicalnewstoday.comOpinion Pieces Respond To Findings That Women Paying More Than Men For Same Health Insurance The following summarizes an editorial and opinion piece that respond to a recent report detailing gender discrimination in
health insurance premiums from the National Women's Law Center. Summaries appear below.~
Source: www.medicalnewstoday.comRoyal Society Comment On Which? Report On Nanomaterials In Cosmetics The Royal Society(1) today commented on a new Which? report(2) that has found that nanomaterials are being used in a wide range of cosmetics. Professor Dame Ann Dowling, Chair of the Royal Society working group on nanotechnologies, said: "We highlighted in our study in 2004 that nanoparticles of a chemical can have different properties to the same chemical in its larger form. And this is why nanoparticles are so exciting.
Source: www.medicalnewstoday.com
# posted by Network @ 2:00 PM
